Sunshine Biopharma Inc. Quarterly Debt-to-equity in % from Q2 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sunshine Biopharma Inc. quarterly Debt-to-equity history and growth rate from Q2 2012 to Q3 2024.
  • Sunshine Biopharma Inc. Debt-to-equity for the quarter ending September 30, 2024 was 25.4 %, a 16.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 25.4 -4.95 -16.3% Sep 30, 2024
Q2 2024 27 +6.97 +34.8% Jun 30, 2024
Q1 2024 26.6 +13.8 +108% Mar 31, 2024
Q4 2023 28.8 +21.7 +307% Dec 31, 2023
Q3 2023 30.4 +27.6 +989% Sep 30, 2023
Q2 2023 20.1 +9.23 +85.3% Jun 30, 2023
Q1 2023 12.8 -60.9 -82.6% Mar 31, 2023
Q4 2022 7.08 +394 Dec 31, 2022
Q3 2022 2.79 +280 Sep 30, 2022
Q2 2022 10.8 +263 Jun 30, 2022
Q1 2022 73.6 +285 Mar 31, 2022
Q4 2021 -387 -225 -138% Dec 31, 2021
Q3 2021 -277 -146 -111% Sep 30, 2021
Q2 2021 -252 -138 -120% Jun 30, 2021
Q1 2021 -212 -97.8 -85.9% Mar 31, 2021
Q4 2020 -163 +1.34 +0.82% Dec 31, 2020
Q3 2020 -131 +114 +46.5% Sep 30, 2020
Q2 2020 -114 +333 +74.4% Jun 30, 2020
Q1 2020 -114 +922 +89% Mar 31, 2020
Q4 2019 -164 +498 +75.2% Dec 31, 2019
Q3 2019 -245 +126 +33.9% Sep 30, 2019
Q2 2019 -447 -190 -73.6% Jun 30, 2019
Q1 2019 -1.04K -853 -468% Mar 31, 2019
Q4 2018 -661 -523 -376% Dec 31, 2018
Q3 2018 -371 -235 -174% Sep 30, 2018
Q2 2018 -258 -46.2 -21.9% Jun 30, 2018
Q1 2018 -182 +149 +44.9% Mar 31, 2018
Q4 2017 -139 +274 +66.4% Dec 31, 2017
Q3 2017 -135 +223 +62.3% Sep 30, 2017
Q2 2017 -211 +24.3 +10.3% Jun 30, 2017
Q1 2017 -331 -114 -52.6% Mar 31, 2017
Q4 2016 -413 -234 -131% Dec 31, 2016
Q3 2016 -358 -209 -140% Sep 30, 2016
Q2 2016 -236 -80.2 -51.6% Jun 30, 2016
Q1 2016 -217 -74.9 -52.8% Mar 31, 2016
Q4 2015 -179 -39.8 -28.5% Dec 31, 2015
Q3 2015 -149 -4.78 -3.31% Sep 30, 2015
Q2 2015 -155 -2.25 -1.47% Jun 30, 2015
Q1 2015 -142 -500 -140% Mar 31, 2015
Q4 2014 -139 -163 -693% Dec 31, 2014
Q3 2014 -145 -169 -680% Sep 30, 2014
Q2 2014 -153 -170 -1031% Jun 30, 2014
Q1 2014 358 +337 +1648% Mar 31, 2014
Q4 2013 23.5 -4.14 -15% Dec 31, 2013
Q3 2013 24.9 +11.3 +82.5% Sep 30, 2013
Q2 2013 16.5 +4.03 +32.4% Jun 30, 2013
Q1 2013 20.5 Mar 31, 2013
Q4 2012 27.7 Dec 31, 2012
Q3 2012 13.7 Sep 30, 2012
Q2 2012 12.4 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.